
Swedish biopharma Anocca has raised approximately ยฃ32m (SEK 440m) to support the early-stage clinical development of VIDAR-1, its lead TCR-T …

Representatives of more than 200 life sciences organisations have urged the UK government to protect the sector from spending cuts. …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

